Bottneuro aims to become a leading provider of diagnosis and device based, non-invasive electric stimulation therapies for Alzheimer disease (AD). None of the pharmacological treatments available today slow or stop the progress of this fatal disease. Our NENI® neuromodulation platform technology enables a fast and reliable validation of novel stimulation protocols targeting glial cells which play an important role in the progress of AD. In Switzerland more than 150'000 people are affected by AD causing yearly costs of about CHF 10 billion and are a huge burden for the family members as well. We plan to start with clinical trials in 2022 and expect to launch our first product in Switzerland beginning of 2025. We have a strong team with a broad expertise and several years of experience.
Location: Germany, North Rhine-Westphalia, Dusseldorf
Employees: 11-50
Total raised: $4.3M
Founded date: 2021
Investors 3
| Date | Name | Website |
| - | DART Ventu... | dart.ventu... |
| - | DART Labs | dartlabs.i... |
| 10.06.2024 | Venture Ki... | venturekic... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 15.12.2022 | - | $4.3M | - |
Mentions in press and media 16
| Date | Title | Description |
| 21.07.2025 | Drei Startups verstärken ihre Verwaltungsräte | Das Zürcher Food-Startup kaisin. kann neu auf das Wissen, die Erfahrungen und Kompetenzen von Bettina Heinzmann im Verwaltungsrat zählen. Heinzmann, Mitgründerin des Women in Retail Switzerland + Friends Netzwerks, bringe breites Fachwisse... |
| 11.06.2025 | The New Wave of Leadership and Innovation in Swiss Startups | In the heart of Switzerland, a revolution is brewing. Startups are not just sprouting; they are evolving. With fresh leadership and innovative products, these companies are poised to reshape their industries. The recent appointments of new ... |
| 10.06.2025 | Neue Power für Startup-Geschäftsleitungen | Payrexx, ein hierzulande führender Zahlungsdienstleister für KMU, ernennt Hendrik Schulenburg zum neuen Chief Financial Officer (CFO). Der 24-jährige Ökonom kam 2021 während seinem Bachelor in Business Administration an der Frankfurt Schoo... |
| 27.11.2024 | Development milestones to propel Medtechs to next step | Following the approval from Health Canada, Aktiia has launched its cuffless bracelet in Canada, marking its first market outside Europe. The Health Canada-approved medical device represents a significant advancement in the measurement of b... |
| 11.11.2024 | Strong startup delegation at Medica 2024 | With over 6,100 international exhibitors and a total of 83,000 trade visitors, Medica is the world's leading trade fair for the medical technology industry. Slated to take place from 11-14 November in Düsseldorf, the trade fair brings toge... |
| 06.09.2024 | Kickfund invests at full throttle | Kickfund Ventures Fund I is a new investment fund dedicated to enhancing Switzerland's innovation ecosystem by supporting deep tech startups have successfully participated in the Venture Kick competition. With an initial closing of CHF 70 ... |
| 08.08.2024 | Bottneuro launches Priority Access Program after successful study | Bottneuro is a Medtech startup from the University of Basel, dedicated to transforming neurological treatments. Their innovative neuromodulation therapy, Miamind®, uses MRI/PET data to deliver precise stimulation. Bottneuro is pioneering w... |
| 08.01.2024 | Bottneuro advances into the clinical phase | |
| 24.11.2023 | Bottneuros Hirnstimulator bereit für den Einsatz an Patienten | |
| 15.12.2022 | Bottneuro secures CHF 4 million to develop its non-invasive Alzheimer's treatment | Private and institutional investors such as DART labs, HEMEX, and Zühlke Ventures are supporting Bottneuro in its mission to fight Alzheimer's Disease (AD). In light of the aging population, this will be one of the biggest challenges of the... |
Show more